PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 13 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Evidence of broad-spectrum antibacterial and antiviral activity, including against Mycobacterium tuberculosis, Yersinia pseudotuberculosis, Staphylococcus aureus, and Ortopox virus [PMID:30834150].
Aqueous extracts from the mycelium of L. officinalis are considered a perspective strain for producing antiviral medicines against avian and human influenza viruses [PMID:22339706].
Ethanolic extracts were analyzed for in vitro anti-inflammatory, antioxidant, and cytotoxic properties relevant to treating DED [PMID:40110128].
Evidence summary
PubMed sources
- 1.PMID: 39988639 (2025) — Mycochemistry, Traditional Uses, and Nutraceutical Potential of Laricifomes officinalis: A Biotechnological and Pharmacological Perspective. · Plant foods for human nutrition (Dordrecht, Netherlands)
- 2.PMID: 30834150 (2019) — Antimicrobial properties of Fomitopsis officinalis in the light of its bioactive metabolites: a review. · Mycology
- 3.PMID: 24786572 (2014) — European medicinal polypores--a modern view on traditional uses. · Journal of ethnopharmacology
- 4.PMID: 27840500 (2016) — "Gharikon"/"Agharikon" a Valuable Medicinal Mushroom in Iranian Traditional Medicine. · Iranian journal of medical sciences
- 5.PMID: 40110128 (2025) — Evaluation of in vitro pharmacological activities of medicinal mushrooms in the context of dry eye disease.